Altria Group Inc. MO released
first-quarter 2019 results, with earnings missing the Zacks
Consensus Estimate and declining year on year. This broke the
companyâs six-quarter streak of bottom-line beats. High interest
expenses were a major deterrent on the bottom line. Also, the top
line was unimpressive, thanks to sluggishness in the smokeable
category. Moreover, lower shipment volumes in the smokeable and
smokeless categories dented quarterly results.
Well, these downsides were enough to dampen investorsâ sentiments,
evident from the stockâs decline of nearly 4.7% in the pre-market
trading hours on Apr 25. Notably, shares of the company fell 3.2%
in the past month compared with the industryâs decline of 3.5%.
Quarter in Details
Adjusted earnings of 90 cents per share lagged the Zacks Consensus
Estimate of 92 cents. Earnings declined 5.3% year over year due to
higher interest expenses and reduced adjusted equity earnings
related to AB InBev.
Net revenues contracted 7.9% year over year to $5,628 million.
Lower revenues in the smokeable unit marred top-line performance.
Revenues net of excise taxes fell 6% to $4,389 million. The Zacks
Consensus Estimate was pegged at $4,541 million.
Also, in the quarter under review, gross profit fell 4.3% to $2,811
million from the prior-year quarterâs tally.
Altria Group, Inc. Price, Consensus and EPS Surprise
Altria Group, Inc. Price, Consensus and EPS Surprise | Altria Group, Inc. Quote
Segment Details
Smokeable Products: Net revenues in the category
fell 8.8% year over year to $4,935 million, thanks to lower
shipment volumes. This was partially offset by higher pricing and
lower promotional investments. Revenues net of excise taxes
contracted 7% year over year to $3,732 million.
Total shipment volume in the category declined 14.1% from the
prior-year quarterâs tally. Also, domestic cigarette shipment
volumes dropped 14.3% year over year due to inventory movements,
lower cigarette industry volumes, decline in retail share and
one-less shipping day. During the quarter, the companyâs total
cigarette retail share dipped 0.7 percentage point to reach
49.8%.
Adjusted OCI in the segment slid 0.2% to $1,991 million due to
lower shipment volumes. The downside was offset by improved pricing
as well as reduced promotional investments and costs. Adjusted OCI
margins improved 3.6 percentage points to 53.3%.
Smokeless Products: Net revenues in the segment
improved 2.9% from the year-ago quarterâs figure to $540 million,
driven by higher pricing and reduced promotional investments. These
were partially countered by low shipment volumes. Also, revenues
net of excise taxes increased 3.2% to $509 million in the
quarter.
Domestic shipment volumes in the category declined 2.2%. Total
smokeless products retail share inched up 0.1 percentage point to
53.9%.
Adjusted OCI rose 7.9% to $367 million owing to improved pricing as
well as reduced promotional investments and costs. These were
partially offset by lower shipment volumes. Adjusted OCI margin
expanded 3.1 percentage points to 72.1%.
Wine: Net revenues increased 6.3% year on year to
$ 151 million, courtesy of higher shipment volumes. The uptick was
partially countered by increased promotional spending. The
segmentâs revenues, net of excise taxes went up 6.6% to $146
million. Wine shipment volume increased 8% to 1.9 million
cases.
Adjusted OCI in the category declined 11.8% to $15 million as a
result of higher costs and promotional expenses, somewhat offset by
improved shipment volume. Adjusted OCI margin contracted 2.1
percentage point to 10.3%.
Financial Updates
In the first quarter, this Zacks Rank #3 (Hold) company paid
dividends worth almost $1.5 billion. The companyâs annualized
dividend rate is currently pegged at $3.20 per share. Further,
management is on track to maintain a payout ratio of 80% of the
bottom line.
Further, the company repurchased 2.7 million shares for
approximately $151 billion in the first quarter. As of Mar 31,
2018, Altria had around $195 million remaining under the share
repurchase program of $2 billion, which is expected to be completed
by the end of second-quarter 2019.
Other Developments
During the quarter, the company closed investment in Cronos Group
Inc CRON, worth almost $1.8 billion. As a result, Altria controls
45% economic and voting rights in Cronos along with a warrant to
acquire additional stake. Also, during the quarter, Altria filed an
application with the U.S. FTC for the conversion of its rights in
JULL to voting securities.
The term loan pertaining to these investments was repaid by Altria
through the issue of debt worth $16.3 billion.
In December, the company revealed a cost-reduction program aimed at
delivering annualized cost savings of nearly $575 million by the
end of 2019. In addition to efforts pertaining to cost-minimization
across several platforms, the program is aimed to reduce workforce
and third-party spending. During the first quarter, the company
recorded pre-tax charges of $61 million in relation to this
program.
Outlook
Management restated the guidance for 2019, wherein it expects
adjusted earnings in the range of $4.15-$4.27, which suggests
year-over-year growth of 4-7%. Moreover, Altria expects domestic
cigarette industry volume to decline in the range of 4-5%. Further,
the company expects 2019 adjusted effective tax rate of
23.5-24.5%.
Looking For Consumer Staples Stocks? Check
These
MEDIFAST MED, with long-term earnings growth rate of 20%, sports a
Zacks Rank #1 (Strong Buy). You can see the complete
list of todayâs Zacks #1 Rank stocks here.
General Mills GIS, with a Zacks Rank #2 (Buy), has long-term
earnings per share growth rate of 7.5%.
Radical New Technology Creates $12.3 Trillion
Opportunity
Imagine buying Microsoft stock in the early days of personal
computers⦠or Motorola after it released the worldâs first cell
phone. These technologies changed our lives and created massive
profits for investors.
Today, weâre on the brink of the next quantum leap in technology. 7
innovative companies are leading this â4th Industrial Revolutionâ -
and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free
report
MEDIFAST INC (MED) : Free
Stock Analysis Report
General Mills, Inc. (GIS) :
Free Stock Analysis Report
Altria Group, Inc. (MO) :
Free Stock Analysis Report
Cronos Group Inc. (CRON) :
Free Stock Analysis Report
To read this article on
Zacks.com click here.
Zacks Investment Research